CraigDaleFisherMD

PubMed

• 52 citations
  Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitis.
  Rhiannon N. Hardwick, Craig D. Fisher, Stephanie M. Street, Mark J. Canet, Nathan J. Cherrington> ;Drug Metabolism and Disposition. 2012 Mar 1
• 102 citations
  Variations in ATP-Binding Cassette Transporter Regulation during the Progression of Human Nonalcoholic Fatty Liver Disease
  Rhiannon N. Hardwick, Craig D. Fisher, Mark J. Canet, George L. Scheffer, Nathan J. Cherrington> ;Drug Metabolism and Disposition. 2011 Dec 1
• 125 citations
  Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease
  April D. Lake, Petr Novák, Craig D. Fisher, Jonathan P. Jackson, Rhiannon N. Hardwick, Dean Billheimer, Walter T. Klimecki, Nathan J. Cherrington> ;Drug Metabolism and Disposition. 2011 Oct 1
• 140 citations
  Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease.
  Rhiannon N. Hardwick, Craig D. Fisher, Mark J. Canet, April D. Lake, Nathan J. Cherrington> ;Drug Metabolism and Disposition. 2010 Dec 1
• 234 citations
  Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease
  Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine, James Ranger-Moore, Jonathan P. Jackson, Stephen S. G. Ferguson, Nathan J. Cherrington> ;Drug Metabolism and Disposition. 2009 Oct 1
• 86 citations
  Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats.
  Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine, Ronald P.J. Oude Elferink, David G. Besselsen, Robert P. Erickson, Nathan J. Cherrington> ;European Journal of Pharmacology. 2009 Jun 24
• Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis.
  Fisher, C. D.,Jackson, J. P.,Lickteig, A. J.,Augustine, L. M.,Cherrington, N. J.> ;Arch. Toxicol.. 2008 May 20
• 37 citations
  The Nrf2 Activator Oltipraz Also Activates the Constitutive Androstane Receptor
  Matthew D. Merrell, Jonathan P. Jackson, Lisa M. Augustine, Craig D. Fisher, Angela L. Slitt, Jonathan M. Maher, Wendong Huang, David D. Moore, Youcai Zhang, Curtis D....> ;Drug Metabolism and Disposition. 2008 Aug 1
• 8 citations
  Gender divergent expression of Nqo1 in Sprague Dawley and August Copenhagen x Irish rats.
  Lisa M. Augustine, Craig D. Fisher, Andrew J. Lickteig, Lauren M. Aleksunes, Angela L. Slitt, Nathan J. Cherrington> ;Journal of Biochemical and Molecular Toxicology. 2008 Mar 1
• 75 citations
  Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease
  Andrew J. Lickteig, Craig D. Fisher, Lisa M. Augustine, Lauren M. Aleksunes, David G. Besselsen, Angela L. Slitt, José E. Manautou, Nathan J. Cherrington> ;Drug Metabolism and Disposition. 2007 Oct 1
• 35 citations
  Genes of the antioxidant response undergo upregulation in a rodent model of nonalcoholic steatohepatitis.
  Andrew J. Lickteig, Craig D. Fisher, Lisa M. Augustine, Nathan J. Cherrington> ;Journal of Biochemical and Molecular Toxicology. 2007 Aug 1
• 92 citations
  Induction of drug-metabolizing enzymes by garlic and allyl sulfide compounds via activation of constitutive androstane receptor and nuclear factor E2-related factor 2.
  Craig D. Fisher, Lisa M. Augustine, Jonathan M. Maher, David M. Nelson, Angela L. Slitt, Curtis D. Klaassen, Lois D. Lehman-McKeeman, Nathan J. Cherrington> ;Drug Metabolism and Disposition. 2007 Jun 1
• 11 citations
  Induction of genes for metabolism and transport by trans-stilbene oxide in livers of Sprague-Dawley and Wistar-Kyoto rats.
  Angela L. Slitt, Nathan J. Cherrington, Craig D. Fisher, Masahiko Negishi, Curtis D. Klaassen> ;Drug Metabolism and Disposition. 2006 Jul 1
• Join now to see all